ResMed Inc. announced earnings results for the second quarter ended December 31, 2018. For the second quarter, the company announced sales was USD 651.100 million compared to USD 601.273 million a year ago. Operating income was USD 157.078 million compared to USD 146.016 million a year ago. Net income was USD 124.639 million compared to USD 9.527 million a year ago. Basic earnings per share was USD 0.87 compared to USD 0.07 a year ago. Diluted earnings per share was USD 0.86 compared to USD 0.07 a year ago. For the half year, sales was USD 1,239.380 million compared to USD 1,124.932 million a year ago. Operating income was USD 301.211 million compared to USD 258.574 million a year ago. Net income was USD 230.377 million compared to USD 95.651 million a year ago. Basic earnings per share was USD 1.61 compared to USD 0.67 a year ago. Diluted earnings per share was USD 1.6 compared to USD 0.67 a year ago.